Journal
BRAIN RESEARCH
Volume 1338, Issue -, Pages 100-111Publisher
ELSEVIER
DOI: 10.1016/j.brainres.2010.03.103
Keywords
miRNA; Neurodegeneration; Tumors; Medulloblastoma; Glioma
Categories
Funding
- Telethon [GGP07118]
- Associazione Italiana per la Ricerca sul Cancro
- Italian Ministry of University and Research (FIRB, PRIN)
- Italian Ministry of Health
- Mariani Foundation
- Roma Foundation
- Pasteur Institute, Cenci Bolognetti Foundation
Ask authors/readers for more resources
The use of miRNAs as biomarkers has gained growing interest in the last few years. Their role in regulating a great variety of targets and, as a consequence, multiple pathways, makes their use in diagnostics a powerful tool to be exploited for early detection of disease, risk assessment and prognosis and for the design of innovative therapeutic strategies. While still not fully validated, profiling of blood cells, exosomes or body fluid miRNAs would represent a tremendous and promising advance in non-invasive diagnostics of CNS disorders. A major challenge is represented by technological aspects of miRNA detection and discovery aiming to genome-wide high throughput, sensitive and accurate analysis. Although there is much to be learned in the field, this review will highlight the potential role of miRNA as a new class of biomarkers in several CNS disorders, including neurodegenerative diseases such as Alzheimer, Huntington and Parkinson diseases, schizophrenia and autism as well as different types of cancer (e.g. gliomas and medulloblastomas). (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available